|
Market Closed -
Nasdaq
16:00:00 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 3.510 USD | +3.24% |
|
-6.65% | +83.77% |
| 08-11 | C4 Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 06-29 | C4 Therapeutics, Inc.(NasdaqGS:CCCC) added to Russell 2000 Index | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| C4 THERAPEUTICS, INC. | Other Biotechnology & Medical Research | +3.24% | -6.65% | +83.77% | +31.95% | -92.84% | 432M |  |  | |
- Stock Market
- Stocks
- CCCC Stock
- Charts C4 Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
